Publication | Closed Access

Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome

Breast OncologyClinical Measures AssociatedMedicineCancer ManagementPatient OutcomePathologyTumor GenotypesBreast CancerCancer TreatmentOncologyRadiation Oncology